Self-management and Cognitive Function in Adults With Heart Failure (Heart ABC)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01461629 |
Recruitment Status :
Completed
First Posted : October 28, 2011
Last Update Posted : April 7, 2016
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
The purpose of this study is to assess the relationship between cognitive impairment, patient self-management, health, and health service use in adults with heart failure (NYHA Class 2 and 3). The research questions are:
- How is cognitive impairment (memory, attention, global and executive function) related to various aspects of impaired self-management (knowledge of adherence, adherence to sodium restriction and medications, symptom monitoring of weight changes, and decision and action to seek care)?
- How are these relationships altered when adjusting for medical, demographic, and psychosocial factors?
- What are the relationships among degree of cognitive impairment, quality self-management, health status, and health service use?
Condition or disease |
---|
Cognitive Impairment Cardiac Disease Heart Failure |
Study Type : | Observational |
Actual Enrollment : | 372 participants |
Observational Model: | Case-Only |
Time Perspective: | Prospective |
Official Title: | Cognitive Impairment and Self-management in Adults With Heart Failure |
Study Start Date : | June 2010 |
Actual Primary Completion Date : | April 2015 |

Group/Cohort |
---|
heart failure
left systolic heart failure (EF </= 40%)
|

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 55 Years to 85 Years (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- documented systolic heart failure
- NYHA class II, III of at least 6 months duration
- 50-85 years of age
- has a telephone (land line) or be willing to allow a telephone installed for duration of study
Exclusion Criteria:
- history of neurological disorder or injury
- moderate or severe head injury
- past or current history of severe psychiatric illness; specifically, psychotic disorders and bipolar disorder
- 5 year past or current history of alcohol or drug abuse
- history of learning disorder or developmental disability
- renal failure requiring dialysis
- history of sleep apnea
- current home telemonitoring program to assist w/ HF self-management
- cardiac surgery < 3 months

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01461629
United States, Ohio | |
Summa Health System | |
Akron, Ohio, United States, 44309 |
Responsible Party: | Tony Vehovec, Associate Professor, Kent State University |
ClinicalTrials.gov Identifier: | NCT01461629 |
Other Study ID Numbers: |
10217650 10217650 ( Other Grant/Funding Number: NHLBI ) |
First Posted: | October 28, 2011 Key Record Dates |
Last Update Posted: | April 7, 2016 |
Last Verified: | April 2016 |
cognitive impairment cognitive function hospitalization |
self-management cardiac disease heart failure |
Heart Failure Heart Diseases Cognitive Dysfunction Cardiovascular Diseases |
Cognition Disorders Neurocognitive Disorders Mental Disorders |